Key facts about Lasmiditan
What dosages is Lasmiditan available in?
Lasmiditan is available as a 50 mg and 100 mg oral tablet.
What is Lasmiditan used for?
Lasmiditan is a serotonin agonist and is used to treat migraines with or without aura in adults.
How does Lasmiditan work?
Lasmiditan is a serotonin agonist, which means it works on serotonin receptors in your brain and activates them (wakes them up). It’s not exactly known how Lasmiditan helps with migraines, but when serotonin receptors are activated, they block pain signals.
How do I take Lasmiditan?
Lasmiditan is typically dosed as 50 mg, 100 mg, or 200 mg by mouth once as needed when you have a migraine attack. Don’t take more than 1 dose in a 24-hour period.
Is it safe for me to take Lasmiditan?
Lasmiditan is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Lasmiditan Common Side Effects
Common side effects of Lasmiditan:
- Dizziness
- Numbness or tingling
- Sleepiness
- Tiredness
Lasmiditan Serious Side Effects
Serious side effects are rare with Lasmiditan. Contact your healthcare provider immediately if you experience any of the following.
- Serotonin syndrome: fast heart rate, sweating, muscle stiffness or spasms, fever, confusion
- Serious allergic reactions: swelling of your face, lips, tongue, or throat, difficulty breathing, hives
Effects of other drugs, drug classes and over-the-counter products on Lasmiditan
The following medications may interact with Lasmiditan:
- Lasmiditan may further lower heart rate when administered with heart rate lowering drugs
Who makes Lasmiditan?
Various FDA-approved generic manufacturers
Is Lasmiditan safe in pregnancy?
It is not known if Lasmiditan can harm an
unborn baby. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Notify your healthcare provider if you become pregnant during treatment or plan to become pregnant.
There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Lasmiditan during
pregnancy. Healthcare providers are encouraged to register pregnant patients, or pregnant women may enroll themselves
in the registry by calling 1-833-464-4724. To learn more please call or visit Migraine pregnancy registry
